Corneal and External Disorders

The FDA has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, a novel prescription eye drop developed by Alcon, for the treatment of both the signs and symptoms of the condition.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important ...

Watch this short, engaging animation to learn more about how the formulations of artificial tears can help relieve dry eye symptoms.

Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.

In this expert Q&A, we speak with Dr Samir Jabbour, Assistant Clinical Professor at the University of Montreal and Adjunct Clinical Professor at McGill University, who also practices at the Centre hospitalier de l'Université de Montréal (CHUM) and Jewish General Hospital (JGH). Dr Jabbour shares insights from his presentation on the evolving role of combining refractive procedures with corneal crosslinking (CXL) for patients with keratoconus and post-refractive ectasia. He discusses clinical indications, patient selection, benefits and risks of simultaneous versus sequential approaches, and the technologies driving the next wave of personalized corneal treatments.